Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcifediol soft capsules to reduce hospital admissions in adults with SARS-CoV-2 infection
2021-000316-31Phase 3Terminated
- Sponsor
- Faes Farma
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Calcifediol (Hidroferol) arm with Placebo arm (2 arms). Primary endpoint: Hospital admission due to SARS-CoV-2 infection. Started Jul 2021; status: terminated.
02
Drugs
calcifediol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-000316-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000316-31.